Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Med LifeLTS:0RO5 67 Equity-to-Asset is 0.15 as of Mar. 2026, which is 17% below its 10-year median of 0.18. GuruFocus rates LTS:0RO5 with a GF Score™ of 67/100 and a GF Value™ of lei1.41 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Med Life ranks worse than 86.03% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Med Life's Total Stockholders Equity for the quarter that ended in Mar. 2026 was lei494 Mil. Med Life's Total Assets for the quarter that ended in Mar. 2026 was lei3,336 Mil.
Therefore, Med Life's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.15.
The historical rank and industry rank for Med Life's Equity-to-Asset or its related term are showing as below:
LTS:0RO5'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.14 Med: 0.18 Max: 0.25
Current: 0.15
During the past 11 years, the highest Equity to Asset Ratio of Med Life was 0.25. The lowest was 0.14. And the median was 0.18.
LTS:0RO5's Equity-to-Asset is ranked worse than 86.03% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs LTS:0RO5: 0.15
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Med Life Equity-to-Asset Related Terms
Med Life Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Med Life's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0RO5 vs HCA, THC, DVA: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Med Life's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Life Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Med Life's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Med Life's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med Life (LTS:0RO5) has a Equity-to-Asset of 0.15 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Med Life and its competitors. This is 17% below median its historical median of 0.18. Over the past decade, Med Life's Equity-to-Asset has ranged from 0.14 to 0.25. According to the industry distribution chart, Med Life ranks #591 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 86%.
Is Med Life's Equity-to-Asset too high?
Med Life's current Equity-to-Asset of 0.15 is 17% below median its 10-year median of 0.18. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 0.25. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Med Life's value of 0.15 is 68.8% below this industry median. Based on the distribution chart, Med Life ranks #591 out of 687 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Med Life has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Med Life ranks #591 out of 687 companies for Equity-to-Asset. This places Med Life in the lower half of its industry. The industry median Equity-to-Asset is 0.48. Med Life's value of 0.15 is 68.8% below this benchmark. Historically, Med Life's own Equity-to-Asset has ranged from 0.14 to 0.25 over the past decade. While the company's 10-year median is 0.18 vs. the industry median of 0.48, Med Life has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med Life's current Equity-to-Asset of 0.15 is 68.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Med Life and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Life's current Equity-to-Asset is 0.15, which is 17% below median its own 10-year median of 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (LTS:0RO5) is currently considered Significantly Overvalued. The stock's GF Value™ is lei1.41, compared to a current price of lei11.62 — trading 724.1% above its estimated fair value. The current Equity-to-Asset is 0.15, which is 17% below median its 10-year median of 0.18 and 68.8% below the Healthcare Providers & Services industry median of 0.48. Med Life's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Med Life (LTS:0RO5), the current Equity-to-Asset is 0.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Med Life (LTS:0RO5) Overvalued in 2026?
Based on GuruFocus' analysis, Med Life stock appears to be overvalued.
The current stock price of lei11.62 is trading 724.1% above its estimated GF Value™ of lei1.41.
GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for LTS:0RO5:
Equity-to-Asset: 0.15 (17% below median its 10-year median of 0.18)
GF Value™: lei1.41 vs. price of lei11.62 (724.1% above fair value)
Industry Position: 68.8% below the Healthcare Providers & Services median (#591 of 687)
No single metric tells the full story. See the LTS:0RO5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
67GF Score
Get the complete analysis for LTS:0RO5
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RO5 has been successfully added to your 
